On December 18, 2020, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19)
Moderna COVID-19 VaccineU.S. Food and Drug AdministrationInformation about the Moderna COVID-19 Vaccine